- Trials with a EudraCT protocol (63)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
63 result(s) found for: Motivation.
Displaying page 1 of 4.
EudraCT Number: 2015-000054-37 | Sponsor Protocol Number: ITM0514 | Start Date*: 2015-07-06 |
Sponsor Name:Institute of Tropical Medicine | ||
Full Title: Be-PrEP-ared: HIV prevention with Pre-exposure prophylaxis – a demonstration project in high risk men having sex with men in Belgium | ||
Medical condition: HIV prevention | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-005894-22 | Sponsor Protocol Number: P060604 | Start Date*: 2007-03-26 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Evaluation de l'efficacité des traitements substitutifs nicotiniques (dispositifs transdermiques délivrant la nicotine pendant 16h/24h) chez 400 femmes enceintes fumeuses. Essai multicentrique, nat... | |||||||||||||
Medical condition: Dépendance nicotinique chez la femme enceinte. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002475-32 | Sponsor Protocol Number: 050526 FMS | Start Date*: 2005-12-07 |
Sponsor Name:Charitè Universitätmeditin Berlin | ||
Full Title: Pilotstudy about endocrinilogical, peripherphysilogical and painreducing effects of Gamma-hydroxybutyrate in combination with operant-behaviour-therapeutic paintherapy with patients in Fibromyalgia... | ||
Medical condition: Patients with Fibromyalgia-syndrome | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-001352-36 | Sponsor Protocol Number: DOPAREAD1 | Start Date*: 2014-12-19 |
Sponsor Name: | ||
Full Title: The effect of dopamine on reading motivation and achievement. | ||
Medical condition: There are no medical conditions or diseases under investigation. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-004054-28 | Sponsor Protocol Number: Panorexia | Start Date*: 2020-06-23 | ||||||||||||||||
Sponsor Name:Imperial College London | ||||||||||||||||||
Full Title: Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study | ||||||||||||||||||
Medical condition: Anorexia Nervosa | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000579-40 | Sponsor Protocol Number: D1443L00002 | Start Date*: 2007-10-10 | |||||||||||
Sponsor Name:Charité Universitätsmedizin Berlin | |||||||||||||
Full Title: Effects of atypical versus typical neuroleptics on motivation, hedonia, and social cognition in patients with schizophrenia – an fMRI study | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003201-81 | Sponsor Protocol Number: GFVT01026904 (GACHE) | Start Date*: 2006-12-20 |
Sponsor Name:Universitätsklinikum Heidelberg | ||
Full Title: GACHE: German trial of Acyclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis. A multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial. | ||
Medical condition: Herpes simplex virus type-1 (HSV-1) is the most frequent cause of fatal sporadic encephalitis in humans. Herpes simplex encephalitis (HSE) was one of the first viral infections to be successfully t... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-000492-17 | Sponsor Protocol Number: NL39440.029.10 | Start Date*: 2012-10-29 |
Sponsor Name:Afdeling Klinische Neuropsychologie Vrije Universiteit Amsterdam | ||
Full Title: The Effects of Long-acting Methylphenidate on Academic Activity and Related Constructs in Children with ADHD: A Randomised Placebo Controlled Trial | ||
Medical condition: Attention-deficit hyperactivity disorder (ADHD) | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000596-16 | Sponsor Protocol Number: EETTMK:99/2011 | Start Date*: 2012-03-19 | |||||||||||
Sponsor Name:Lapland Hospital District/ Lapland Central Hospital | |||||||||||||
Full Title: Smoking Cessation of Young Adults in Northern Finland | |||||||||||||
Medical condition: Healthy daily smoking young adults aged 18-26 years | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002731-28 | Sponsor Protocol Number: P12-01/BP1.4979 | Start Date*: 2013-03-01 | |||||||||||
Sponsor Name:Bioprojet | |||||||||||||
Full Title: Randomized placebo controlled trial assessing the efficacy and safety of BP1.4979 in smoking cessation | |||||||||||||
Medical condition: Smoking cessation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004409-24 | Sponsor Protocol Number: AK130940 | Start Date*: 2005-06-08 |
Sponsor Name:GlaxoSmithKline Research & Development | ||
Full Title: A Multi-Centre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Flexible Dose Study to Evaluate the Efficacy, Safety and Tolerability of Extended-Release Bupropion Hydrochloride (150m... | ||
Medical condition: Major Depressive Disorder (MDD) | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SK (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-001386-16 | Sponsor Protocol Number: TUD-TEMACA-069 | Start Date*: 2019-07-16 |
Sponsor Name:Technische Universität Dresden | ||
Full Title: Investigation of the efficacy of acamprosate and calcium in comparison to placebo as validation of a behavioural test for alcohol dependence (TEMACA) | ||
Medical condition: persons with disturbance in alcohol use according DSM5 which do not want to change their alcohol consumption | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2022-001563-26 | Sponsor Protocol Number: NCT05355337 | Start Date*: 2022-10-03 | |||||||||||
Sponsor Name:Region Skåne | |||||||||||||
Full Title: Pramipexole for Anhedonic Depression (PRIME-PRAXOL) | |||||||||||||
Medical condition: The effect of nine weeks of treatment with the dopamine agonist Pramipexole in patients with depression with clinically significant anhedonia will be evaluated with symptom rating scales, blood and... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001365-32 | Sponsor Protocol Number: 19CX5006 | Start Date*: 2019-07-25 | |||||||||||
Sponsor Name:Imperial Joint Research Compliance Office | |||||||||||||
Full Title: IP4- CHRONOS: Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer | |||||||||||||
Medical condition: Prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-001244-15 | Sponsor Protocol Number: D22-P006 | Start Date*: 2023-01-12 |
Sponsor Name:GHU Paris Psychiatrie et Neurosciences | ||
Full Title: Efficiency of a composite personalised care on functional outcome in early psychosis: A Prospective Randomised Controlled Trial - PsyCARE_Trial | ||
Medical condition: early psychosis | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000576-38 | Sponsor Protocol Number: CARL | Start Date*: 2022-06-08 | |||||||||||
Sponsor Name:UNIVERSITA' DEGLI STUDI DI CAMERINO | |||||||||||||
Full Title: Effect of treatment of the cholinergic precursor Choline Alfoscerate in mild cognitive dysfunction | |||||||||||||
Medical condition: Mild cognitive dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002369-14 | Sponsor Protocol Number: CHUB-Psy-PAThforsAUD | Start Date*: 2023-07-20 | |||||||||||
Sponsor Name:CHU Brugmann | |||||||||||||
Full Title: Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy & (Neuro)cognitive Mechanisms. | |||||||||||||
Medical condition: Severe Alcohol Use Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002513-11 | Sponsor Protocol Number: 331-10-230 | Start Date*: 2012-01-09 | |||||||||||
Sponsor Name:Otsuka Pharmaceutical Development & Commercialization, Inc. | |||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed dose OPC-34712 (4, 2, and 1 mg/day) in the Treatment of Adults With Acute Schizophrenia | |||||||||||||
Medical condition: Acute Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-003803-19 | Sponsor Protocol Number: WXL101497 | Start Date*: 2004-11-10 |
Sponsor Name:GlaxoSmithKline Research & Development | ||
Full Title: A Multi-Centre, Randomised, Double-Blind, Parallel-Group, Placebo- and Active- Controlled, Flexible Dose Study Evaluating the Efficacy, Safety and Tolerability of Extended-Release Bupropion Hydroch... | ||
Medical condition: Major Depressive Disorder (MDD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-007060-28 | Sponsor Protocol Number: 1/2006 | Start Date*: 2007-05-31 | |||||||||||
Sponsor Name:Cruz Bartolome Moreno | |||||||||||||
Full Title: "Influencia de la fase del ciclo hormonal en la efectividad de nicotina y bupropion para ayudar a dejar de fumar" "Influence of the fase of the hormone´s cicle in the efectivity of nicotine and Bup... | |||||||||||||
Medical condition: "Deshabituación tabáquica en mujeres" "Smoking cessation in women" | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
